跳至主要内容
临床试验/NCT02687074
NCT02687074Unknown不适用

Effects of High Flow Nasal Canula on Moderate and Severe Respiratory Failure Patients

Southeast University, China0 个研究点目标入组 246 人开始时间: 2016年1月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
246
主要终点
intubation rate on 28 days

研究概览

简要总结

Respiratory failure is the danger for the patients admitted in ICU, mechanical ventilation could save a lot of patients' life, however, it prolongs patients' ICU stay and hospital stay. High flow nasal cannula (HFNC) has advantages of PEEP effects, reducing dead space, increasing EELV and improving comfort, and it has been used to treat respiratory failure patients. In recent study, HFNC could improve mortality of respiratory failure patients with P/F<200mmHg in the subgroup. The investigators want to start a randomized controlled study to evaluate the effects of HFNC on the patients with respiratory failure.

详细描述

just as the brief summary

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age>18 years
  • patients met all four of the following criteria:
  • a respiratory rate of more than 25 breaths per minute,
  • a ratio of the partial pressure of arterial oxygen (Pao2) to the Fio2 of 300 mm Hg or less while the patient was breathing oxygen at a flow rate of 10 liters per minute or more for at least 15 minutes,
  • a partial pressure of arterial carbon dioxide (Paco2) not higher than 45 mmHg, and
  • an absence of clinical history of underlying chronic respiratory failure

排除标准

  • Paco2 of more than 45 mm Hg
  • exacerbation of asthma or chronic respiratory failure
  • cardiogenic pulmonary edema
  • severe neutropenia
  • hemodynamic instability, use of vasopressors,
  • Glasgow Coma Scale score of 12 points or less (on a scale from 3 to 15, with lower scores indicating reduced levels of consciousness)
  • contraindications to noninvasive ventilation
  • urgent need for endotracheal intubation, a do-not-intubate order, and a decision not to participate.

结局指标

主要结局

intubation rate on 28 days

时间窗: up to 28 days

次要结局

  • Duration of ICU stay(date of death from any cause, whichever came first, assessed up to 90 days)
  • Duration of hospital stay(date of death from any cause, whichever came first, assessed up to 90 days)

研究者

发起方
Southeast University, China
申办方类型
Other
责任方
Principal Investigator
主要研究者

Chun Pan

Principal Investigator

Southeast University, China

相似试验